A Randomized, Placebo-controlled Study to Explore Safety, Dose and Efficacy of NBMI in a Mercury Intoxicated Population

Trial Profile

A Randomized, Placebo-controlled Study to Explore Safety, Dose and Efficacy of NBMI in a Mercury Intoxicated Population

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Apr 2017

At a glance

  • Drugs Emeramide (Primary)
  • Indications Heavy metal poisoning
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Ermes Medical Company
  • Most Recent Events

    • 06 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 16 Mar 2016 According to a EmeraMed media release, the results of Phase 2a trial of Emeramide for mercury intoxication is expected in early spring of 2016.
    • 10 Mar 2016 Planned End Date changed from 1 Jan 2016 to 1 Apr 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top